Nashville, TN, United States of America

Samantha M Sarett

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Vanderbilt University. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samantha M Sarett. Retrieved from https://idiyas.com/inventor/samantha-m-sarett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Samantha M Sarett

Introduction

Samantha M Sarett is an accomplished inventor based in Nashville, TN (US). She has made significant contributions to the field of pharmacokinetics and gene silencing. With a total of 2 patents, her work is recognized for its innovative approach to improving drug delivery systems.

Latest Patents

Samantha's latest patents focus on the conjugation of lipophilic albumin-binding moieties to RNA. This innovative method aims to enhance carrier-free in vivo pharmacokinetics and gene silencing. The compounds she developed include RNA directly conjugated to an albumin-binding group. The method involves administering this compound to a subject in need, showcasing her commitment to advancing medical science.

Career Highlights

Samantha M Sarett is affiliated with Vanderbilt University, where she continues her research and development in the field. Her work has garnered attention for its potential applications in therapeutic settings.

Collaborations

Some of her notable coworkers include Craig L Duvall and Thomas A Werfel, who contribute to her research endeavors.

Conclusion

Samantha M Sarett's innovative work in pharmacokinetics and gene silencing exemplifies the impact of her research on modern medicine. Her contributions are paving the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…